Envoy Medical, Inc. SEC filings COCHW

Envoy Medical, Inc. has 328 filings in SEC EDGAR's recent list, going back to Jan 19, 2021. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.

Envoy Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Oct 27, 2026 Oct 23, 2026
8-K Current report
Shareholder vote results
Oct 16, 2026 Oct 12, 2026
8-K Current report
Other events
Oct 7, 2026 Oct 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 14, 2026 —
DEFA14A Additional proxy material Sep 2, 2026 —
DEF 14A Proxy statement Aug 31, 2026 Oct 12, 2026
8-K Current report
Officer or director change
Aug 27, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
PRE 14A Preliminary proxy statement Aug 19, 2026 Aug 19, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Agreement ended
Jun 30, 2026 Jun 24, 2026
8-K Current report
Officer or director change
Jun 25, 2026 Jun 19, 2026
4 Insider transaction Jun 23, 2026 Jun 19, 2026
EFFECT Filing Jun 16, 2026 —
POS AM Post-effective amendment no. 1 to form s-1 Jun 12, 2026 —
S-8 Employee stock plan registration Jun 12, 2026 —
4 Insider transaction Jun 4, 2026 May 29, 2026
8-K Current report
Listing notice
May 22, 2026 May 19, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 18, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 11, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
8-K Current report
Officer or director change
Apr 21, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
3 Initial insider ownership Apr 17, 2026 Apr 15, 2026
10-K/A Amended annual report Apr 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 2, 2026 May 12, 2026
8-K Current report
Auditor change
Mar 31, 2026 Mar 25, 2026
8-K Current report
Results of operations
Mar 27, 2026 Mar 23, 2026
PRE 14A Preliminary proxy statement Mar 23, 2026 Mar 23, 2026
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Listing notice, Other events
Feb 27, 2026 Feb 23, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 17, 2026 —
8-K Current report
Material agreement, Other events
Feb 13, 2026 Feb 11, 2026
424B4 Prospectus Feb 12, 2026 —
424B4 Prospectus Feb 12, 2026 —
EFFECT Filing Feb 11, 2026 —
8-K Current report
Officer or director change
Feb 11, 2026 Feb 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2026 —
S-1MEF Registration statement Feb 11, 2026 —
S-1/A Amended registration statement Feb 10, 2026 —
CORRESP Letter to the SEC Feb 9, 2026 —
CORRESP Letter to the SEC Feb 9, 2026 —
4 Insider transaction Feb 9, 2026 Feb 5, 2026
4 Insider transaction Feb 9, 2026 Feb 5, 2026
S-1/A Amended registration statement Feb 6, 2026 —
EFFECT Filing Dec 30, 2025 —
8-K Current report
Material agreement
Dec 29, 2025 Dec 18, 2025
CORRESP Letter to the SEC Dec 23, 2025 —
S-1 Registration statement Dec 18, 2025 —
8-K Current report
Regulation FD disclosure
Dec 16, 2025 Dec 16, 2025
4 Insider transaction Dec 10, 2025 Nov 28, 2025
SCHEDULE 13D Ownership over 5% (active) Dec 8, 2025 —
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
8-K Current report
Shareholder vote results
Dec 3, 2025 Nov 26, 2025
S-1/A Amended registration statement Dec 1, 2025 —
8-K Current report
Listing notice
Nov 25, 2025 Nov 19, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Listing notice, Other events
Oct 28, 2025 Oct 23, 2025
DEF 14A Proxy statement Oct 17, 2025 Nov 26, 2025
S-1 Registration statement Oct 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 9, 2025 Oct 7, 2025
424B5 Prospectus supplement Oct 9, 2025 —
PRE 14A Preliminary proxy statement Oct 7, 2025 Oct 7, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 23, 2025 Sep 22, 2025
424B5 Prospectus supplement Sep 23, 2025 —
424B5 Prospectus supplement Sep 22, 2025 —
8-K Current report
Other events
Sep 19, 2025 Sep 19, 2025
8-K Current report
Material agreement
Sep 9, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
UPLOAD Letter from the SEC Sep 2, 2025 —
8-K Current report
Listing notice
Aug 29, 2025 Aug 26, 2025
DRSLTR Filing Aug 27, 2025 —
DRS Filing Aug 27, 2025 —
8-K Current report
Agreement ended, Officer or director change
Aug 26, 2025 Aug 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 21, 2025 —
424B3 Prospectus Aug 21, 2025 —
EFFECT Filing Aug 11, 2025 —
POS AM Post-effective amendment no. 2 to form s-1 on form s-3 Aug 8, 2025 —
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
POS AM Post-effective amendment no. 1 to form s-1 on form s-3 Jul 29, 2025 —
8-K Current report
Material agreement
Jul 29, 2025 Jul 28, 2025
4 Insider transaction Jul 8, 2025 Jun 26, 2025
3 Initial insider ownership Jul 3, 2025 Jun 23, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Jul 2, 2025 Jun 26, 2025
8-K Current report
Officer or director change
Jun 25, 2025 Jun 19, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 9, 2025 Nov 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 3, 2025 May 28, 2025
4 Insider transaction May 27, 2025 May 22, 2025
8-K Current report
Officer or director change
May 19, 2025 May 16, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 18, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 18, 2025 —
DEF 14A Proxy statement Apr 18, 2025 May 28, 2025
8-K Current report Apr 11, 2025 Apr 10, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
4 Insider transaction Mar 13, 2025 Mar 11, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 12, 2025 Mar 6, 2025
8-K Current report
Listing notice
Mar 3, 2025 Feb 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2025 —
424B5 Prospectus supplement Jan 21, 2025 —
8-K Current report
Material agreement
Jan 21, 2025 Jan 17, 2025
SCHEDULE 13D Ownership over 5% (active) Dec 26, 2024 —
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 20, 2024
424B3 Prospectus Dec 23, 2024 —
8-K Current report
Material agreement
Dec 23, 2024 Dec 19, 2024
424B3 Prospectus Dec 20, 2024 —
8-K Current report
Material agreement, Change to shareholder rights
Dec 20, 2024 Dec 20, 2024
4 Insider transaction Dec 17, 2024 Dec 11, 2024
424B3 Prospectus Dec 17, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 17, 2024 Dec 11, 2024
4 Insider transaction Dec 13, 2024 Dec 11, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
8-K Current report
Shareholder vote results
Nov 20, 2024 Nov 14, 2024
424B3 Prospectus Nov 14, 2024 —
424B3 Prospectus Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
EFFECT Filing Oct 21, 2024 —
CORRESP Letter to the SEC Oct 17, 2024 —
UPLOAD Letter from the SEC Oct 10, 2024 —
ARS Annual report to shareholders Oct 4, 2024 Dec 31, 2023
DEFA14A Additional proxy material Oct 4, 2024 —
DEF 14A Proxy statement Oct 4, 2024 Nov 14, 2024
S-3 Shelf registration Oct 3, 2024 —
4 Insider transaction Sep 11, 2024 Sep 9, 2024
8-K Current report Sep 6, 2024 Sep 6, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
424B3 Prospectus Aug 28, 2024 —
8-K Current report
Material agreement, Other events
Aug 28, 2024 Aug 27, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
424B3 Prospectus Aug 12, 2024 —
424B3 Prospectus Aug 12, 2024 —
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Other events
Aug 1, 2024 Jul 31, 2024
424B3 Prospectus Aug 1, 2024 —
8-K Current report
Material agreement
Aug 1, 2024 Jul 29, 2024
424B3 Prospectus Jul 25, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Jul 25, 2024 Jul 22, 2024
4 Insider transaction Jul 24, 2024 Jul 22, 2024
424B3 Prospectus Jul 17, 2024 —
424B3 Prospectus Jul 17, 2024 —
8-K Current report
Regulation FD disclosure
Jul 15, 2024 Jul 15, 2024
4 Insider transaction Jun 26, 2024 Jun 24, 2024
424B3 Prospectus Jun 25, 2024 —
8-K Current report
Material agreement
Jun 25, 2024 Jun 24, 2024
3 Initial insider ownership Jun 17, 2024 Jun 7, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 11, 2024 Jun 6, 2024
424B3 Prospectus May 29, 2024 —
4 Insider transaction May 28, 2024 May 23, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
May 24, 2024 May 23, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
EFFECT Filing May 2, 2024 —
424B3 Prospectus May 2, 2024 —
CORRESP Letter to the SEC Apr 30, 2024 —
S-1/A Amended registration statement Apr 25, 2024 —
S-8 Employee stock plan registration Apr 12, 2024 —
S-1/A Amended registration statement Apr 5, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
4 Insider transaction Mar 4, 2024 Feb 27, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 4, 2024 Feb 27, 2024
S-1/A Amended registration statement Feb 15, 2024 —
CORRESP Letter to the SEC Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
UPLOAD Letter from the SEC Jan 29, 2024 —
S-1 Registration statement Jan 18, 2024 —
10-Q/A Amended quarterly report Jan 17, 2024 Sep 30, 2023
8-K Current report
Restatement
Dec 19, 2023 Dec 14, 2023
4/A Amended statement of changes in beneficial ownership of securities Dec 4, 2023 Nov 20, 2023
4 Insider transaction Nov 24, 2023 Nov 21, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
COCH (Nasdaq), COCHW (Nasdaq)
Fiscal year ends
December 31
Headquarters
White Bear Lake, MN
SEC filer status
, Emerging growth company
SEC CIK
1840877
Former names
Anzu Special Acquisition Corp I (until Sep 29, 2023)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.